Evaluation of three prognostic indexes in follicular lymphoma
R. Sidhu(Amgen (United States)), Tara Baetz(Queen's University), Harriet Feilotter(University Health Network), David P. LeBrun(BC Cancer Agency)
Cited by 0
Related Papers
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
|Annals of Oncology|2014|603
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
|Annals of Oncology|2013|220
Faecal lactoferrin – a novel test to differentiate between the irritable and inflamed bowel?
|Alimentary Pharmacology & Therapeutics|2010|57
Low rates of serious complications but high rates of hardware removal after high tibial osteotomy with Tomofix locking plate
|Knee Surgery Sports Traumatology Arthroscopy|2020|42